| 9/2011 - Present |
Associate Professor and Faculty Physician |
University of Texas Health Science Center, Psychiatry, San Antonio, TX |
| 1/2011 - Present |
Director, Psychosomatic Medicine Fellowship and Director |
University of Texas Health Science Center, Psychiatry, San Antonio, TX |
| 9/2010 - Present |
Medical Director |
University Hospital Psychiatric Services,, Psychiatry, San Antonio, TX |
| 5/2010 - Present |
Director |
Psychiatric Consultation Liaison Service, University of Texas Health Science Center at San Antonio, Psychiatry, San Antonio, TX |
| Date |
Description |
Institution |
# Students |
| 7/2010 - Present |
Psychiatry Case Conference Series |
University Hospital- San Antonio, TX |
25 students |
| Initiated case conference series to enhance educational goals of residents and medical students. |
| 1/2010 - Present |
Individual Instruction |
The University of Texas Health Science Center at San Antonio |
|
|
| 7/2009 - Present |
Individual Instruction |
The University of Texas Health Science Center at San Antonio |
|
|
| 10/2006 - Present |
University Hospital Psychiatric Consultation Liaison Service |
University Hospital - The University of Texas Health Science Center at San Antonio |
136 students |
| Supervision of MS III |
| 10/2006 - Present |
University Hospital Psychiatric Consultation Liaison Service |
University Hospital - The University of Texas Health Science Center at San Antonio |
110 students |
| Supervision of PG II psychiatry residents, PG IV psychiatry residents and neurology residents. |
| 3/2005 - Present |
|
UTHSCSA |
|
|
| 1/2004 - Present |
Supervisor, Psychiatry Residents |
University of Texas Health Science Center in San Antonio |
|
| Reading Elective with focus on Psychopharmacology. |
| 10/2002 - Present |
University Hospital Psychiatric Emergency Services |
University Hospital |
200 students |
| Supervision of PG I & PG II psychiatry residents. |
| 10/2002 - Present |
University Hospital Psychiatric Emergency Services |
University Hospital |
200 students |
| Supervision of MS III. |
Journal Article |
| Bowden CL, Perlis RH, Thase ME, Ketter TA, Ostacher MM, Calabrese JR, Reilly-Harrington NA, Gonzalez JM, Singh V, Nierenberg, AA, Sachs GS. Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) CNS Neuroscience & Therapeutics 2011 Jan;:In-Press.
|
| Thompson PM, Gonzalez JM, Singh V, Schoolfield, John, Katz, Martin M, Bowden CL. Principal domains of behavioral psychopathology identified by the Bipolar Inventory of Signs and Symptoms Scale (BISS) Psychiatry Research 2010 Feb;175(3):221-226.
|
| Bernardo CG, Singh V, Thompson PM. Safety and Efficacy of Psychopharmacological Agents Used to Treat the Psychiatric Sequelae of Common Neurological Disorders-Accepted Expert Opinion in Drug Safety 2008 Jan;.
|
| Gonzalez JM, Bowden CL, Katz MM, Thompson PM, Singh V, Prihoda TJ, Dahl M. Development of the Bipolar Inventory of Symptoms Scale: Concurrent validity, discriminant validity and retest reliability International Journal of Methods in Psychiatric Research 2008 Jan;17(4):198-209.
|
| Bowden CL, Singh V, Thompson PM, Gonzalez JM, Katz, MM, Dahl, M, Prihoda TJ, Chang, X. Development of the Bipolar Inventory of Symptoms Scale Acta Psychiatrica Scandinavica 2007 Sep;116(3):189-194.
|
Book Chapter |
| Bowden C, Singh V. Valproate. In: Akiskal H, Tohen M (Eds). Bipolar Psychopharmacotherapy: Caring for the patient (second edition). West Sussex, UK: John Wiley & Sons; 2011. p. 25-30.
|
Abstract |
| Singh V, Bowden CL, Weisler, Richard, Thompson PM, Mintz J. Randomized, Double Blind 8-MonthMaintenance Study of Bipolar Depression with Lamotrigine or Divalproex ER plus Lamotrigine; 2009 Nov. (American College of Neuropsychopharmacology Annual Meeting).
|
| Singh V. Sensitivity of a Comprehensive Rating Scale for Bipolar Disorders (BD) to Assess Improvements with Treatment; 2009 Oct. (International Society for CNS Clinical Trial and Methodology Autumn Conference).
|
| Bowden CL, Gonzalez JM, Singh V, Thompson PM, Bernardo CG,. Sensitivity of a Comprehensive Rating Scale for Bipolar Disorders (BD) to Assess Improvements with Treatment; 2009 Aug. (European Neuropsychopharmacology Annual Meeting).
|
| Singh V, Bowden C. Relative Efficacy of Open Label Adjunctive Risperidone on Manic and Depressive Symptoms in Mixed Mania; 2009 Jun. (Poster - New Clinical Drug Evaluation Unit (NCEDU) 2009).
|
| Singh V, Bowden C. Relative Efficacy of Open Label Adjunctive Risperidone on Manic and Depressive Symptoms in Mixed Mania Florida; 2009 Jun. (New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting).
|
| Singh V, Thompson PM, Bernardo CG, Bowden CL. Safety and Efficacy of Lamotrigine As Add on Treatment in Mixed States (MS) of Bipolar Disorder (BD); 2008 Apr. (Society of Biological Psychiatry Annual Meeting; vol. 63, no. 7S1).
|
| Singh V, Bowden CL, Bernardo CG, Thompson PM. 8-Month Maintenance Treatment of Bipolar Depression (BD) with Lamotrigine (LAM) or Divalproex (DIV) plus LAM: Acute Phase Safety and Efficacy of Combined LAM and DIV Treatment of BD; 2008 Apr. (Society of Biological Psychiatry Annual Meeting; vol. 63, no. 7S).
|
| Singh V, Bowden CL, Weisler, R., Thompson PM. Open phase safety and efficacy of lamotrigine (LAM) plus divalproex (DIV) treatment of bipolar depression (BD) in patients with bipolar disorder (BP); 2008 Feb. (Internation Society for Bipolar Disorders Annual Meeting; vol. 10, no. Supl-).
|
| Thompson PM, Gonzalez JM, Singh V, Schoolfield, J, Bowden CL. Principal Domains of Behavioral Psychopathology Identified by the Bipolar Inventory of Symptoms Scale (BISS) Annual Meeting; 2007 Dec. (American College of Neuropsychopharmacology Annual Meeting).
|
Other |
| Singh V. Differential Response of Depressive and Manic Symptoms in Mixed States (MS) of Bipolar Disorder New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting 2009 Jun;.
|
Federal |
| Funding Agency |
National Institute of Mental Health (NIMH) |
| Title |
Optiminzing Outcomes in Bipolar illness Interventions in Hispanic Communities |
| Status |
Active |
| Period |
9/2011 - 6/2016 |
| Role |
Co-Investigator |
| Grant Detail |
An Advanced Center for Interventions and/or Service Research was established to conduct research that will personalize community based treatment of bipolar disorders to improve outcomes. We will investigate interactions of cultural factors, adherence and engagement, behavioral domains and biological factors with outcomes, thereby providing a model that can transform current diagnostic and treatment paradigms for bipolar disorder. A major aim of this proposal is to better develop our understanding of bipolar disorder in the Hispanic American population, in particular the impact of acculturation on adherence to treatment programs. These efforts will equip us to serve as a national resource to advance the NIMH mission of reducing the burden of bipolar illness and improve outcomes through the efforts of research about treatments and their acceptability to patients, and broadly disseminate this research for the purposes of improving clinical care, public education and public health planning. |
| Funding Agency |
NIMH |
| Title |
Administrative Supplement to Bipolar Illness Intervention in Hispanic Communities |
| Status |
Active |
| Period |
9/2009 - 4/2011 |
| Role |
Co-Investigator |
| Grant Detail |
The purpose of this proposal is to upgrade the data management and data base components of our Developing Center for Interventions and Service Research in Bipolar Disorders (DCISR) and utilize the data base developed through the several activities of the DCISR to conduct an analysis with broad public health significance. We will re-engineer and expand the functions of the data base management system including: front end entry, data storage, web based entry from extramural sites and more effective querying procedures. These advances will serve participating investigators, public sector clinicians and lay individuals who may thereby learn about research results and improve their effective knowledge about bipolar recognition and treatment. |
Private |
| Funding Agency |
Cyberonics, Inc. |
| Title |
Randomized Comparison of Outcomes in Patients with Treatment-Resistant Depression who receive VNS Therapy Administered at Different Amounts of Electrical Charge |
| Status |
Active |
| Period |
12/2005 - Present |
| Role |
Co-Principal Investigator |
| Grant Detail |
This study is being done to compare different device settings(doses)for VNS Therapy with people who have treatment resistant depression. |
| Funding Agency |
Institute for Integration of Medicine and Science- Clinical and Translation Science Award |
| Title |
Mechanisms of action of TMS Treatment in Depression |
| Status |
Active |
| Period |
- Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
Repligen Corporation |
| Title |
A Phase II Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Safety, Tolerability and Efficacy of RG2417 (Uridine) in the Treatment of Bipolar I Depression |
| Status |
Complete |
| Period |
7/2009 - 6/2011 |
| Role |
Co-Investigator |
| Grant Detail |
This study aims to assess the efficacy of RG2417 in Bipolar I Depression by demonstrating a greater improvement in the Montgomery-Asberg Depression Rating Scale (MADRS) when compared to placebo. |
State |
| Funding Agency |
Research Imaging Center |
| Title |
An Open-Label Treatment Pilot Study to Evaluate the Efficacy and Safety of the Image-guided, Robotically-positioned Repetitive Transcranial Magnetic Stimulation (rTMS) System in Subjects with Major Depression |
| Status |
Active |
| Period |
4/2007 - Present |
| Role |
Co-Investigator |
| Grant Detail |
The purpose of this proposal is to evaluate the safety and efficacy of novel Image-guided, Robotically-positioned Transcranial Magnetic Stimulation (irTMS) treatment in patients with Major Depression. Safety and efficacy data from this pilot study will be used to generate R01 grant applications for further study of the irTMS system. |
